ENTITY

Generate Biomedicines (GENB US)

9
Analysis
Health Care • United States
Generate Biomedicines, Inc. operates as a clinical-stage generative biology company. The Company focuses on machine learning, biological engineering, and AI to generate optimal therapeutics for the impact on human health. Generate Biomedicines serves patients and healthcare professionals worldwide.
more
Exchange Announcement • 06 Aug 2026 18:01

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 06 Aug 2026 18:00

Current Report (Form 8-K | Period ending 2026-08-06)

Exchange Announcement • 07 May 2026 18:01

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

Exchange Announcement • 07 May 2026 18:00

Current Report (Form 8-K | Period ending 2026-05-07)

Exchange Announcement • 03 Mar 2026 06:22

Current Report (Form 8-K | Period ending 2026-02-26)

x